Cargando…
Androgen receptor status predicts development of brain metastases in ovarian cancers
Brain metastases are uncommon localizations in epithelial ovarian cancer (EOC), their reported incidence is increasing and no predictive biomarkers have been identified yet. Goals of this study were: i) to define a possible association between Estrogen Receptor (ER), Progesterone Receptor (PR), Andr...
Autores principales: | Mittica, Gloria, Senetta, Rebecca, Scotto, Giulia, Aglietta, Massimo, Maggiorotto, Furio, Ghisoni, Eleonora, Genta, Sofia, Boldorini, Renzo, Manini, Claudia, Morra, Isabella, Buosi, Roberta, Sapino, Anna, Cassoni, Paola, Valabrega, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522232/ https://www.ncbi.nlm.nih.gov/pubmed/28467804 http://dx.doi.org/10.18632/oncotarget.17068 |
Ejemplares similares
-
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2020) -
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
por: Mittica, Gloria, et al.
Publicado: (2017) -
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
por: Ghisoni, Eleonora, et al.
Publicado: (2019) -
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019) -
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
por: Ghisoni, Eleonora, et al.
Publicado: (2018)